Investigation of alpha nascent polypeptide-associated complex functions in a human CD8+ T cell ex vivo expansion model using antisense oligonucleotides

Immunology

Volumn 112, Issue 3, 2004, Pages 397-403

  Al Shanti, N ^a   Steward, C G ^a,b   Garland, R J ^a   Rowbottom, A W ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Royal Hospital for Children   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

NAC; Antisense oligonucleotides; CD8+ T cell

Indexed keywords

ALPHA NASCENT POLYPEPTIDE COMPLEX; ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; CD3 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; PHOSPHOROTHIOIC ACID; POLYPEPTIDE; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL KINETICS; CELL STIMULATION; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOLECULAR MODEL; MOLECULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

ANTIGENS, CD3; ANTIGENS, CD57; BLOTTING, NORTHERN; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR CHAPERONES; OLIGONUCLEOTIDES, ANTISENSE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATORS;

EID: 3042800736     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01893.x     Document Type: Article

References (30)

1. + T cells. J Exp Med 1997; 186:1407-18.
2. + T-cell development. Immunol Today 1999; 20:177-81.
3. Kubagawa H, Abo T, Balch CM, Cooper MD. Biochemical analysis of antigenic determinants recognized by HNK-1 (leu-7) antibody. Fed Proc 1983; 42:1219-24.
4. Schroder J, Nikinmaa B, Kavathas P, Herzenberg LA. Fluorescence-activated cell sorting of mouse-human hybrid cells aids in locating the gene for the Leu 7 (HNK-1) antigen to human chromosome 11. Proc Natl Acad Sci U S A 1983; 80:3421-4.
5. Joly P, Guillon JM, Mayaud C et al. Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. J Immunol 1989; 143:2193-201.
6. + lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients. Clin Exp Immunol 1992; 89:143-7.
7. + cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analysis. Clin Exp Immunol 1993; 94:297-305.
8. + lymphocytes from AIDS patients inhibits T cell cytotoxicity. Eur J Immunol 1991; 21:737-41.
9. + lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. Blood 1991; 77:2237-41.
10. + suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. J Immunol 1986; 137:2180-9.
11. - precursor by differentiation occurring in late immune responses. J Immunol 1994; 24:1503-11.
12. Mollet L, Sadat-Sowti B, Duntze J et al. CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol 1998; 10:311-23.
13. Wiedmann B, Sakai H, Davis TA, Wiedmann M. A protein complex required for signal-sequence-specific sorting and translocation. Nature 1994; 370:434-40.
14. Yotov WV, Moreau A, St-Arnaud R. The alpha chain of the nascent polypeptide associated complex function as a transcriptional coactivator. Mol Cell Biol 1998; 18:1303-11.
15. + cytotoxic T lymphocytes. J Immunol Methods 1999; 27:53-63.
16. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10.
17. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989.
18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
19. Hartmann G, Krug A, Bidlingmaier M et al. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes. J Pharm Exp Ther 1998; 285:920-8.
20. + T-cell ex vivo expansion model. Scand J Immunol 2003; 58:462-70.
21. Wiedmann B, Prehn S. The nascent polypeptide associated complex (NAC) of yeast functions in the targeting process of ribosomes to the ER membrane. FEBS Lett 1999; 458:51-4.
22. Moller I, Jung M, Beatrix B et al. A general mechanism for regulation of access to the translocon: competition for a membrane attachment site on ribosomes. Proc Natl Acad Sci USA 1998; 95:13425-30.
23. Vollenweider I, Lazzarato M, Groscurth P. proliferation of IL-2 activated lymphocytes preferably occurs in aggregates by cells expressing the CD57 antigen. Scand J Immunol 1995; 42:381-6.
24. Cantrell D. The structure of the T cell antigen receptor. Annu Rev Immunol 1996; 14:259-74.
25. Clements JL, Boerth NJ, Lee JR, Koretzky GA. Integration of T cell receptor-dependent signaling pathways by adaptor proteins. Annu Rev Immunol 1999; 17:89-108.
26. Germain RN, Stefanova I. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu Rev Immunol 1999; 17:467-522.
27. Nakamura Y, Russell SM, Mess SA, Friedmann M, Erdos M et al. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling. Nature 1994; 369:330-3.
28. Nelson BH, Lord JD, Greenberg PD. Cytoplasmic domains of the interleukin-2 receptor beta and gamma chains mediate the signal for T-cell proliferation. Nature 1994; 369:333-6.
29. Stilo R, Liguoro D, di Jeso B, Leonardi A, Vito P. The alpha-beta chain of the nascent polypeptide associated complex binds to and regulates FADD function. Biochem Biophys Res Commun 2003; 303:1034-41.
30. Zhang G, Cado D, Chen A, Kabra NH, Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 19:296-300.